DRUG-MONITORING IN CANCER-THERAPY

被引：8

作者：

HANDE, KR

机构：

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1991年 / 83卷 / 21期

关键词：

D O I：

10.1093/jnci/83.21.1523

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1523 / 1524

页数：2

共 7 条

[1]

BENNETT CL, 1987, CANCER RES, V47, P1952

[2]

EVANS WE, 1990, P AN M AM SOC CLIN, V9, P69

[3] SYSTEMIC EXPOSURE TO MERCAPTOPURINE AS A PROGNOSTIC FACTOR IN ACUTE LYMPHOCYTIC-LEUKEMIA IN CHILDREN [J].

KOREN, G ;

FERRAZINI, G ;

SULH, H ;

LANGEVIN, AM ;

KAPELUSHNIK, J ;

KLEIN, J ;

GIESBRECHT, E ;

SOLDIN, S ;

GREENBERG, M .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (01) :17-21

[4] MODELING INTERPATIENT PHARMACODYNAMIC VARIABILITY OF ETOPOSIDE [J].

MICK, R ;

RATAIN, MJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (21) :1560-1564

[5] THERAPEUTIC DRUG-MONITORING IN ONCOLOGY - PROBLEMS AND POTENTIAL IN ANTINEOPLASTIC THERAPY [J].

MOORE, MJ ;

ERLICHMAN, C .

CLINICAL PHARMACOKINETICS, 1987, 13 (04) :205-227

[6] PHARMACODYNAMICS IN CANCER-THERAPY [J].

RATAIN, MJ ;

SCHILSKY, RL ;

CONLEY, BA ;

EGORIN, MJ .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (10) :1739-1753

[7] PHARMACOLOGICALLY BASED DOSING OF ETOPOSIDE - A MEANS OF SAFELY INCREASING DOSE INTENSITY [J].

RATAIN, MJ ;

MICK, R ;

SCHILSKY, RL ;

VOGELZANG, NJ ;

BEREZIN, F .

JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (08) :1480-1486

← 1 →